← Open Payments lookup

AMANDA BRINK: Open Payments

NPI 1568871101 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,455 in 17 payments from 14 companies in 2025. Trend: 2023 $2,487 · 2024 $2,890 · 2025 $1,455

Food & beverage: $1,363Honoraria: $58Speaker / faculty: $34
CompanyPaymentsAmount
Corcept Therapeutics2$206
Janssen Biotech, Inc.2$164
Abbott Laboratories1$146
Amgen Inc.1$138
Pharmacosmos Therapeutics Inc.1$125
Xeris Pharmaceuticals, Inc.1$107
Bayer Healthcare Pharmaceuticals Inc.1$100
VERTEX PHARMACEUTICALS INCORPORATED1$96
Becton, Dickinson and Company2$92
Gilead Sciences, Inc.1$87

Products named: Korlym, RYBREVANT, PROCLAIM, COSELA, RECORLEV, Vitrakvi, JOURNAVX, Epclusa.

Industry payments across TX — which companies pay providers there.